Breaking News
Get 40% Off 0
These stocks are up over 10% post earnings. Did you spot the buying opportunity? Our AI did. Read how
Close

Precision BioSciences Inc (DTIL)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Precision BioSciences's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
10.3100 -0.6200    -5.67%
- Real-time Cboe. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 25,747
  • Bid/Ask: 0.0000 / 0.0000
  • Day's Range: 10.2300 - 10.9000
Precision BioSciences 10.3100 -0.6200 -5.67%

Precision BioSciences Inc Company Profile

 
Get an in-depth profile of Precision BioSciences Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

115

Equity Type

ORD

Precision BioSciences, Inc., an advanced gene editing company, develops in vivo gene editing therapies for gene edits, including gene elimination, insertion, and excision in the United States. The company offers ARCUS, a genome editing platform to DNA genome insertion, deletion, and repair. It also provides PBGENE-HBV for the treatment of chronic hepatitis B virus (HBV) to eliminate covalently closed circular DNA with direct cuts and edits as well as to inactivate integrated HBV DNA with the goal of long-lasting reductions in hepatitis B surface antigen; PBGENE-PMM for the treatment of m.3243 associated primary mitochondrial myopathy (PMM) which is expected to submit an IND and/or CTA. In addition, it develops PBGENE-NVS for sickle cell disease/beta thalassemia for insertion; PBGENE-DMD (excision) for duchenne muscular dystrophy; PBGENE-LL2 (insertion), a liver directed target; PBGENE-LL3, a central nervous system directed target; and iECURE-OTC (insertion) for ornithine transcarbamylase deficiency. The company has license and collaboration agreement with Caribou Biosciences, Inc.; license agreement with TG Cell Therapy, Inc. to develop, manufacture, and commercialize azer-cel for autoimmune diseases and other indications outside of cancer; development and license agreement with Eli Lilly and Company for the research and development of potential in vivo therapies for genetic disorders; Cellectis S.A.; iECURE, Inc. to develop ARCUS-based gene-insertion therapies; Duke University; and Novartis Pharma AG to discover and develop in vivo gene editing products. Precision BioSciences, Inc. was incorporated in 2006 and is headquartered in Durham, North Carolina.

Contact Information

Address 302 East Pettigrew Street Suite A-100
Durham, 27701
United States
Phone 919 314 5512
Fax 480 393 5553

Top Executives

Name Age Since Title
Michael Amoroso 43 2021 President, CEO & Director
Kenneth C. Anderson 72 2019 Member of Scientific Advisory Board
Samuel C. Wadsworth 75 2021 Independent Director
Stanley R. Frankel 63 2021 Independent Director
Geno J. Germano 62 2020 Independent Director
Shari Lisa Pire 58 2021 Independent Director
Raymond F. Schinazi 73 2019 Member of Scientific Advisory Board
Cameron J. Turtle - 2019 Member of Scientific Advisory Board
Hagop M. Kantarjian - 2019 Member of Scientific Advisory Board
Samuel E. Broder 78 2018 Member of Scientific Advisory Board
Melinda Brown 67 2022 Independent Director
Kevin J. Buehler 66 2019 Independent Lead Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

DTIL Comments

Write your thoughts about Precision BioSciences Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Andrew Doutt
Andrew Doutt Sep 21, 2023 12:55PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
why...
Михаил Кузнецов
Михаил Кузнецов Jun 22, 2022 10:49AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
He took a decent position here at 1.45. Insider purchases were discovered, they obviously know something.
Aleksi Kumpumäki
Aleksi Kumpumäki Jan 19, 2021 11:57AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Why so much rocketing
Hamilton Deatherage
Hamilton Deatherage Jan 19, 2021 11:57AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
because its time
Exchange Watchdog
Exchange Watchdog Jan 19, 2021 10:57AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Finally the irrationality is gone
Hamilton Deatherage
Hamilton Deatherage Dec 22, 2020 3:10PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
hope yall bought the dip
Exchange Watchdog
Exchange Watchdog Dec 07, 2020 11:12AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Lol how is this even possible practically all other gene editing comp are mooning
Joe Sesto
Joe Sesto Dec 04, 2020 12:21PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Death in trial
Exchange Watchdog
Exchange Watchdog Dec 03, 2020 12:39PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Someone knows why this is dropping?
Exchange Watchdog
Exchange Watchdog Nov 23, 2020 12:24PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I'm never selling this stock, easy 10x
Exchange Watchdog
Exchange Watchdog Nov 20, 2020 7:30AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Literally 15 min after i find this gem and placed my order at 9.6, this fkkr shoots up over 12
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email